Patrick John Finn - Sep 2, 2021 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
Chief Commercial Officer
Signature
/s/ William Solis, as Attorney-in-Fact for Patrick John Finn
Stock symbol
TWST
Transactions as of
Sep 2, 2021
Transactions value $
-$255,914
Form type
4
Date filed
9/7/2021, 05:26 PM
Previous filing
Aug 26, 2021
Next filing
Oct 6, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Options Exercise $3.16K +358 +0.9% $8.82 40.2K Sep 2, 2021 Direct
transaction TWST Common Stock Options Exercise $40.4K +1.52K +3.78% $26.66 41.7K Sep 2, 2021 Direct
transaction TWST Common Stock Options Exercise $19.3K +827 +1.98% $23.33 42.5K Sep 2, 2021 Direct
transaction TWST Common Stock Sale -$319K -2.7K -6.35% $117.99* 39.8K Sep 2, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -358 -2.24% $0.00 15.6K Sep 2, 2021 Common Stock 358 $8.82 Direct F2
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -1.52K -3.7% $0.00 39.4K Sep 2, 2021 Common Stock 1.52K $26.66 Direct F3
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -827 -3.7% $0.00 21.5K Sep 2, 2021 Common Stock 827 $23.33 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 3, 2020.
F2 The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vest on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F3 20% of the shares subject to the option vested and became exercisable on October 31, 2019, and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F4 25% of the shares subject to the option vested and became exercisable on October 24, 2020, and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.